Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology
- PMID: 26542657
- DOI: 10.1016/j.jacc.2015.09.035
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology
Keywords: ACC/AHA Scientific Statements; arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathy; cardiovascular abnormalities; cardiovascular magnetic resonance; hypertrophic cardiomyopathy; myocarditis; sudden death.
Similar articles
-
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.Circulation. 2015 Dec 1;132(22):e273-80. doi: 10.1161/CIR.0000000000000239. Epub 2015 Nov 2. Circulation. 2015. PMID: 26621644 Review. No abstract available.
-
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.J Am Coll Cardiol. 2015 Dec 1;66(21):2356-2361. doi: 10.1016/j.jacc.2015.09.034. Epub 2015 Nov 2. J Am Coll Cardiol. 2015. PMID: 26542659 No abstract available.
-
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.Circulation. 2015 Dec 1;132(22):e256-61. doi: 10.1161/CIR.0000000000000236. Epub 2015 Nov 2. Circulation. 2015. PMID: 26621642 Review. No abstract available.
-
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 14: Sickle Cell Trait: A Scientific Statement From the American Heart Association and American College of Cardiology.J Am Coll Cardiol. 2015 Dec 1;66(21):2444-2446. doi: 10.1016/j.jacc.2015.09.046. Epub 2015 Nov 2. J Am Coll Cardiol. 2015. PMID: 26542668 No abstract available.
-
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations: A Scientific Statement From the American Heart Association and American College of Cardiology.J Am Coll Cardiol. 2015 Dec 1;66(21):2447-2450. doi: 10.1016/j.jacc.2015.09.047. Epub 2015 Nov 2. J Am Coll Cardiol. 2015. PMID: 26542663 No abstract available.
Cited by
-
Effect and mechanism of T lymphocytes on human induced pluripotent stem cell-derived cardiomyocytes via Proteomics.Stem Cell Res Ther. 2024 Jul 29;15(1):236. doi: 10.1186/s13287-024-03791-4. Stem Cell Res Ther. 2024. PMID: 39075540 Free PMC article.
-
Multiparametric Mapping via Cardiovascular Magnetic Resonance in the Risk Stratification of Ventricular Arrhythmias and Sudden Cardiac Death.Medicina (Kaunas). 2024 Apr 24;60(5):691. doi: 10.3390/medicina60050691. Medicina (Kaunas). 2024. PMID: 38792874 Free PMC article. Review.
-
Short- and Mid-Term Outcomes of Early Alcohol Septal Ablation Therapy for Patients with Mildly Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Tertiary Center Experience.J Clin Med. 2024 Mar 1;13(5):1444. doi: 10.3390/jcm13051444. J Clin Med. 2024. PMID: 38592289 Free PMC article.
-
COVID myocarditis in a collegiate athlete: Timeline and return to play.Am Heart J Plus. 2023 Sep 9;34:100323. doi: 10.1016/j.ahjo.2023.100323. eCollection 2023 Oct. Am Heart J Plus. 2023. PMID: 38510953 Free PMC article.
-
Syncope in Athletes: A Prelude to Sudden Cardiac Death?Mo Med. 2024 Jan-Feb;121(1):52-59. Mo Med. 2024. PMID: 38404441 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
